{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:23Z","timestamp":1786979603106,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,4,29]],"date-time":"2012-04-29T00:00:00Z","timestamp":1335657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00066-012-0098-z","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T04:29:12Z","timestamp":1335500952000},"page":"564-567","source":"Crossref","is-referenced-by-count":28,"title":["Radiation-induced oesophagitis in lung cancer patients","Bestrahlungsinduzierte \u00d6sophagitis bei Lungenkrebspatienten"],"prefix":"10.1007","volume":"188","author":[{"given":"D.","family":"De Ruysscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Vandecasteele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Oberije","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pijls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Reymen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van Baardwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lammering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lambin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"De Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,29]]},"reference":[{"key":"98_CR1","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1200\/JCO.2010.30.3271","volume":"28","author":"De","year":"2010","unstructured":"De Ruysscher D, Faivre-Finn C, Nestle U et al (2010) European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 28:5301\u20135310","journal-title":"J Clin Oncol"},{"key":"98_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00066-007-1593-5","volume":"183","author":"Semrau","year":"2007","unstructured":"Semrau S, Bier A, Thierbach U et al (2007) 6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer. Strahlenther Onkol 183:30\u201335","journal-title":"Strahlenther Onkol"},{"key":"98_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00066-006-1485-0","volume":"182","author":"Gagel","year":"2006","unstructured":"Gagel B, Piroth M, Pinkawa M et al (2006) Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine\/vinorelbine in locally advanced non-small cell lung cancer: a phase I study. Strahlenther Onkol 182:263\u2013269","journal-title":"Strahlenther Onkol"},{"key":"98_CR4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00066-005-1332-8","volume":"181","author":"Catalano","year":"2005","unstructured":"Catalano G, Jereczek-Fossa BA, De Pas T et al (2005) Three-times-daily radiotherapy with induction chemotherapy in locally advanced non-small cell lung cancer. Feasibility and toxicity study. Strahlenther Onkol 181:363\u2013371","journal-title":"Strahlenther Onkol"},{"key":"98_CR5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00066-010-2079-4","volume":"186","author":"Mizumoto","year":"2010","unstructured":"Mizumoto M, Sugahara S, Nakayama H et al (2010) Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther Onkol 186:482\u2013488","journal-title":"Strahlenther Onkol"},{"key":"98_CR6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00066-010-2136-z","volume":"186","author":"Wolff","year":"2010","unstructured":"Wolff HA, Bosch J, Jung K et al (2010) High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer. Strahlenther Onkol 186:262\u2013268","journal-title":"Strahlenther Onkol"},{"key":"98_CR7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00066-011-1111-7","volume":"187","author":"Semrau","year":"2011","unstructured":"Semrau R, Temming S, Preuss SF et al (2011) Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel: a phase II study. Strahlenther Onkol 187:645\u2013650","journal-title":"Strahlenther Onkol"},{"key":"98_CR8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF03038526","volume":"174","author":"Zimmermann","year":"1998","unstructured":"Zimmermann FB, Geinitz H, Feldmann HJ (1998) Therapy and prophylaxis of acute and late radiation-induced sequelae of the esophagus. Strahlenther Onkol 174(Suppl 3):78\u201381","journal-title":"Strahlenther Onkol"},{"key":"98_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF03038549","volume":"174","author":"Belka","year":"1998","unstructured":"Belka C (1998) Oral sucralfate administration for therapy and prevention of radiation-induced esophagitis: results of a placebo-controlled double-blind study. Strahlenther Onkol 174:333\u2013334","journal-title":"Strahlenther Onkol"},{"key":"98_CR10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00066-009-1938-3","volume":"185","author":"Wurstbauer","year":"2009","unstructured":"Wurstbauer K, Merz F, Sedlmayer F (2009) Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study. Strahlenther Onkol 185:512\u2013516","journal-title":"Strahlenther Onkol"},{"key":"98_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2004.06.014","volume":"61","author":"Ahn","year":"2005","unstructured":"Ahn SJ, Kahn D, Zhou S et al (2005) Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 61:335\u2013347","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"98_CR12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2008.09.010","volume":"91","author":"Rose","year":"2009","unstructured":"Rose J, Rodrigues G, Yaremko B et al (2009) Systematic review of dose\u2013volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 91:282\u2013287","journal-title":"Radiother Oncol"},{"key":"98_CR13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijrobp.2009.05.070","volume":"76","author":"Werner-Wasik","year":"2010","unstructured":"Werner-Wasik M, Yorke E, Deasy J et al (2010) Radiation dose\u2013volume effects in the esophagus. Int J Radiat Oncol Biol Phys 76:86\u201393","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"98_CR14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2005.10.001","volume":"77","author":"Chapet","year":"2005","unstructured":"Chapet O, Kong FM, Lee JS et al (2005) Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 77:176\u2013181","journal-title":"Radiother Oncol"},{"key":"98_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.radonc.2010.09.028","volume":"97","author":"Dehing-Oberije","year":"2010","unstructured":"Dehing-Oberije C, De Ruysscher D, Petit S et al (2010) Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients. Radiother Oncol 97:455\u2013461","journal-title":"Radiother Oncol"},{"key":"98_CR16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/annonc\/mdm005","volume":"18","author":"De","year":"2007","unstructured":"De Ruysscher D, Dehing C, Bremer RH et al (2007) Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol 18:909\u2013916","journal-title":"Ann Oncol"},{"key":"98_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijrobp.2009.04.075","volume":"77","author":"Loon","year":"2010","unstructured":"Loon J van, De Ruysscher D, Wanders R et al (2010) Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 77:329\u2013336","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"98_CR18","unstructured":"ICRU (1993) International Commission on Radiation Units and Measurements Report 50: Prescribing, recording, and reporting photon beam therapy"},{"key":"98_CR19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00066-010-2108-3","volume":"186","author":"Wurstbauer","year":"2010","unstructured":"Wurstbauer K, Weise H, Deutschmann H et al (2010) Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses \u2265\u200980\u00a0Gy in standard fractionation. Strahlenther Onkol 186:551\u2013557","journal-title":"Strahlenther Onkol"},{"key":"98_CR20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.radonc.2009.02.010","volume":"91","author":"Pijls-Johannesma","year":"2009","unstructured":"Pijls-Johannesma M, Houben R, Boersma L et al (2009) High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Radiother Oncol 91:443\u2013448","journal-title":"Radiother Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0098-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-012-0098-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0098-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:31:05Z","timestamp":1558564265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-012-0098-z"}},"subtitle":["Is susceptibility for neutropenia a risk factor?","Ist Anf\u00e4lligkeit f\u00fcr Neutropenie ein Risikofaktor?"],"short-title":[],"issued":{"date-parts":[[2012,4,29]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1007\/s00066-012-0098-z","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,29]]}}}